OFs from patients with TAO (#120, #135, #137) showed higher levels of IKKα/β and p65 phosphorylation and a higher level of IκB degradation (Fig 4A), compared to controls (#71, #116, #136). The gene discussed is CHUK; the disease is thromboangiitis obliterans.